|
||
Journal of Experimental Medicine, Vol 169, 585-590, Copyright © 1989 by Rockefeller University Press
ARTICLES |
KS Furukawa, K Furukawa, FX Real, LJ Old and KO Lloyd
Memorial Sloan-Kettering Cancer Center, New York, New York 10021.
Analysis of antibodies present in the serum of melanoma patient FD has shown that they detect a unique tumor epitope present only on the autologous melanoma cell line SK-MEL-131. Previous results had shown that the unique FD epitope is carried on a common glycoprotein of approximately 90 kD, widely expressed on melanoma and a few other cell types. We now show by sequential radioimmunoprecipitation and partial amino acid sequencing that this common molecule is a previously recognized melanoma antigen, originally identified by mouse mAbs, designated gp95 or p97 (and also known as melanotransferrin). Thus, FD is the first of the class I (unique) melanoma antigens that has been characterized and related to a known cell surface molecule.
This article has been cited by other articles:
| TABLE OF CONTENTS |
|